It was another busy week for Australia's top brokers. This has led to a number of broker notes being released.
Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:
Image source: Getty Images
Flight Centre Travel Group Ltd (ASX: FLT)
According to a note out of Macquarie, its analysts have retained their outperform rating and $17.95 price target on the travel agent's shares. This follows the release of a trading update last week, which revealed that the company has retained its guidance for FY 2026. Macquarie was pleased with the news and notes that this reflects a strong corporate performance, which is offsetting disruption in the leisure segment. Together with ongoing cost discipline and productivity gains, the broker believes the company is positioned to grow its earnings over the medium term. The Flight Centre share price ended the week at $10.74.
ResMed Inc. (ASX: RMD)
A note out of Morgans reveals that its analysts have retained their buy rating on this sleep disorder treatment company's shares with a trimmed price target of $41.72. This follows the release of a third-quarter result which Morgans thought was solid. The broker was pleased to see the company deliver double-digit revenue and earnings growth, further margin expansion, and strong cash flow generation. It also points out that investors seem to be focusing on variability in US device growth while pondering if the Noctrix acquisition is merely a plug to a slowing core. However, it views these concerns as myopic and manageable. As a result, Morgans thinks now could be a good time to buy shares. The ResMed share price was fetching $28.56 at Friday's close.
TechnologyOne Ltd (ASX: TNE)
Another note out of Bell Potter reveals that its analysts have upgraded this enterprise software provider's shares to a buy rating with an improved price target of $31.75. This follows news that TechnologyOne has won a new contract with James Cook University. Bell Potter believes this is a major positive from a product perspective. That's because it demonstrates the power of TechnologyOne's Agentic AI product to win contracts. As a result, the broker has boosted its annual recurring revenue (ARR) forecasts for the medium term and is now forecasting ARR of $655 million in FY 2026. This equates to growth of 18% year on year, which is at the top end of the company's 16% to 18% guidance range for the year. The TechnologyOne share price ended the week at $27.99.
